Paradoxically, despite a reduction in blood supply and angiogenesis, the anti-VEGF treatment has been shown to increase tumor cell invasion in GBM (29), potentially due to an enhanced hypoxic microenvironment and a feedback activation of HIF-1a and PI3K. The gene discussed is HIF1A; the disease is neoplasm.